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Abstract. 
 
The catalytic (C) subunit of protein kinase A 
functions both in the cytoplasm and the nucleus. A ma-
jor charge variant representing about one third of the 
enzyme in striated muscle results from deamidation in 
 
vivo of the Asn2 residue at the conserved NH
 
2
 
-terminal 
sequence 
 
myr
 
Gly-Asn-Ala (Jedrzejewski, P.T., A. Gi-
rod, A. Tholey, N. König, S. Thullner, V. Kinzel, and D. 
Bossemeyer. 1998. 
 
Protein Sci.
 
 7:457–469). Because of 
the increase of electronegativity by generation of Asp2, 
it is reminiscent of a myristoyl-electrostatic switch. To 
compare the intracellular distribution of the enzymes, 
both forms of porcine or bovine heart enzyme were mi-
croinjected into the cytoplasm of mouse NIH 3T3 cells 
after conjugation with ﬂuorescein, rhodamine, or in un-
labeled form. The nuclear/cytoplasmic ﬂuorescence ra-
tio (N/C) was analyzed in the presence of cAMP (in the 
case of unlabeled enzyme by antibodies). Under all cir-
cumstances, the N/C ratio obtained with the encoded 
Asn2 form was signiﬁcantly higher than that with the 
deamidated, Asp2 form; i.e., the Asn2 form reached a 
larger nuclear concentration than the Asp2 form. Com-
parable data were obtained with a human cell line. The 
differential intracellular distribution of both enzyme 
forms is also reﬂected by functional data. It correlates 
with the degree of phosphorylation of the key serine in 
CREB family transcription factors in the nucleus. Mi-
 
croinjection of myristoylated recombinant bovine C
 
a
 
 
and the Asn2 deletion mutant of it yielded N/C ratios in 
the same range as encoded native enzymes. Thus, Asn2 
seems to serve as a potential site for modulating elec-
tronegativity. The data indicate that the NH
 
2
 
-terminal 
domain of the PKA C-subunit contributes to the intra-
 
cellular distribution of free enzyme, which can be altered 
by site-speciﬁc in vivo deamidation. The model charac-
ter for other signaling proteins starting with 
 
myr
 
Gly-
Asn is discussed.
Key words: deamidation • myristoylated NH
 
2 
 
termi-
nus • microinjection • myristoyl-electrostatic switch • 
CREB phosphorylation
 
Introduction
 
An increase in cellular cAMP represents a rapid early
metabolic response to a variety of external stimuli. Cyclic
AMP activates the cyclic AMP–dependent protein kinase
A (PKA),
 
1
 
 an abundant multifunctional enzyme. By phos-
phorylation of key substrates, PKA transmits exogenous
signals regulating a large number of cellular processes in
the cytoplasm as well as in the nucleus (for review see
Walsh and Van Patten, 1994). Although different signaling
pathways are propagated through the same protein kinase,
the character as well as the time frame of cellular re-
sponses may differ widely. Whereas cAMP-triggered met-
abolic steps in the cytoplasm are initiated within less than
a minute, cAMP-stimulated nuclear events proceed at a
much slower pace with the maximum occurring only after
 
z
 
30 min (Hagiwara et al., 1993). Control of the intracellu-
lar distribution of the active enzyme is undoubtedly of
great importance (for reviews see Lohmann and Walter,
1984; Nigg, 1990).
In the absence of cAMP, PKA exists largely as an inac-
tive tetrameric holoenzyme consisting of two regulatory
(R) subunits composed of a dimer and two catalytic (C)
subunits (for review see Krebs and Beavo, 1979). The ho-
loenzyme is primarily localized in the cytoplasm or bound
to specific cytoplasmic organelles via anchoring proteins,
depending on the type of R-subunit (for review see Scott,
1991; Hubbard and Cohen, 1993). As sufficient amounts of
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Abbreviations used in this paper:
 
 C, catalytic; CREB, cAMP-respon-
sive element binding protein; N/C, nuclear/cytoplasmic fluorescence;
NMT, 
 
N
 
-myristoyl transferase; PKA, protein kinase A or cAMP-depen-
dent protein kinase; PKI, protein kinase inhibitor; R, regulatory. 
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cAMP become available, up to 4 mol of the nucleotide are
bound to each R-subunit dimer, which in turn liberates two
molecules of monomeric C-subunit. Evidence has been
presented that the free C-subunit can translocate to the
nucleus (Nigg et al., 1985; Meinkoth et al., 1990; Nigg,
1990), although a classical nuclear localization sequence
has not yet been identified. Moreover, it has been shown
that cAMP-stimulated transcription is rate-limited by the
nuclear entry of the enzyme (Hagiwara et al., 1993).
Quantitative data on nuclear entry have been obtained
previously by microinjection of recombinant catalytic sub-
unit C
 
a
 
 (mouse sequence), and were explained by diffu-
sion (Harootunian et al., 1993). Native C-subunit isolated
from tissues carries a long chain fatty acid at the NH
 
2 
 
ter-
minus, mostly myristate, which is absent from the recom-
binant form (Carr et al., 1982). From a comparison of re-
combinant with the native catalytic subunit it was assumed
that myristoylation of the native enzyme was not obliga-
tory for intracellular function, including nuclear entry of
the enzyme (Clegg et al., 1989; Meinkoth et al., 1990).
Recent evidence shows that in the native catalytic sub-
unit, an increase in electronegativity can occur close to
the NH
 
2
 
 terminus through a posttranslational mechanism.
Preparations of the catalytic subunit from striated muscle
of several mammalian species, although homogenous by
SDS gel electrophoresis, have been separated into two
chromatographic fractions, A and B, in many laboratories
on the basis of charge differences. These are not due to
differences in the molar phosphorylation rate (Kinzel et al.,
1987). Based on earlier observations (Hotz et al., 1989), it
recently has been shown by electrospray mass spectrome-
try and sequence analysis of the C-subunit from four dif-
ferent mammalian species (Jedrzejewski et al., 1998) that
fraction B contains the catalytic subunit gene products C
 
a
 
and C
 
b
 
 in the encoded form with Asn at position two
in both cases. Fraction A, which represents consistently
about one third of routine enzyme preparations, contains
C
 
a
 
 and C
 
b
 
 at the same ratio as fraction B but exclusively
in the Asp2 form. The fact that Asp2 is not encoded in C
 
a
 
and C
 
b
 
, and even not allowed in substrates of the 
 
N
 
-myris-
toyl transferase (NMT; for review see Towler et al., 1988),
argues for a posttranslational conversion of Asn2 to Asp2
by deamidation, which is responsible for the 0.4-pH unit
difference of the isoelectric values of the fractions A and
B. Evidence has been presented that indicates that deami-
dation of Asn2 occurs in vivo, i.e., represents a natural
modification (Jedrzejewski et al., 1998) that appears to be
regulated since the deamidated fraction of C-subunit from
striated muscle of different mammalian species represents
reproducibly one third from the total. The regulation of
deamidation of Asn2, however, remains to be elucidated.
The significance of the Asn2 to Asp2 conversion in the
C-subunit is unknown. Effects on the enzyme activity in
the test tube, its reassociation with R-subunits (Kinzel et
al., 1987), or its association with protein kinase inhibitor
(Van Patten et al., 1988) were not observed so far. This
prompted us to ask if such a conserved deamidation of the
C-subunit might influence the localization of the enzyme
in living cells. We determined the nuclear/cytoplasmic dis-
tribution of both forms of porcine and bovine C-subunit
after microinjection into the cytoplasm of cultured cells.
The data show that the nuclear/cytoplasmic ratio approached
 
by the Asp2 form of the enzyme is lower than that ob-
tained with the encoded Asn2 form. Accordingly, the phos-
phorylation of substrate in the nucleus (CREB family
transcription factors) through the deamidated form is
smaller than with the encoded form. It seems that the par-
tial deamidation of the C-subunit at the conserved Asn2 is
aimed at modulating the intracellular distribution as well
as the phosphorylation capacity of free enzyme among the
major cellular compartments.
 
Materials and Methods
 
Catalytic Subunit of the cAMP-dependent Kinase Type 
II from Pig and Bovine Hearts
 
The catalytic subunit of the cAMP-dependent kinase type II from pig and
bovine hearts was prepared as described earlier (Nelson and Taylor, 1981;
Kinzel et al., 1987; Bossemeyer et al., 1993) with minor modifications in-
cluding a scaling up. In brief, hearts were homogenized in 50 mM potas-
sium phosphate buffer, pH 6.5, containing 1 mM EDTA, 2 mM DTT, and
the following protease inhibitors: 0.5 mM PMSF, 0.2 mM TPCK, 0.5 mg/l
leupeptin, 0.7 mg/l pepstatin A, 0.5 mg/l E64, 0.5 mM 
 
N
 
-NH
 
2
 
-capronic
acid, and 0.5 mg/trypsin inhibitor. The homogenate was cleared by centrif-
ugation and filtration through glass wool and bound to DE-52 cellulose
(Whatman). The DE cellulose was washed with 100 mM potassium phos-
phate buffer, pH 6.5, and the holoenzyme was eluted by 300 mM potas-
sium phosphate buffer, pH 6.5. After dilution of the eluate (1:5) the ho-
loenzyme was again bound to DE cellulose. After washes with potassium
phosphate buffer (50 mM, pH 6.5, and 15 mM, pH 6.1), the C subunit was
eluted by cAMP (0.2 mM in buffer A, 15 ml potassium phosphate, 1 mM
EDTA, 0.1 mM DTT) and immediately bound to a small column with
CM-52 cellulose (Whatman). The C-subunit was eluted by a gradient
0–60% buffer B (100 mM Mops, 150 mM KCl, l mM DTT, 0.l mM EDTA,
pH 7) for the first 20 ml; 60–100% buffer B for the next 30 ml. Fractions of
10 ml were collected. From 4-kg hearts, typically, 15–20 mg of electro-
phoretically homogenous C subunit were obtained.
 
Separation of Fraction A and B
 
Up to 2 mg of C-subunit diluted 1:2 by H
 
2
 
O was separated on a Mono S
HR 5/5 column (FPLC-System; Pharmacia). The gradient was pro-
grammed to be 0–22% buffer B (10 mM bis-Tris propane, 1 M LiCl, pH
8.5) 0–12 ml; 22–26% buffer B 12–25 ml; 26–100% buffer B 25–26 ml;
100% buffer 26–50 ml. Flow rate was 0.75 ml/min. The two peaks, at
 
z
 
23% buffer B and 55% buffer B representing enzyme fraction A and B
(see Fig. 1), were collected. Separation of fraction A and B was verified by
isoelectric focusing. Protein kinase activity was assayed as described previ-
ously (Kinzel et al., 1987); the fractions had an equal specific enzyme ac-
tivity. Details of the analysis of fraction A and B by mass spectrometry
have been described elsewhere (Jedrzejewski et al., 1998).
 
Labeling of Enzyme in Fraction A and B with FITC or 
with TRITC
 
Labeling of fraction A and B with FITC or with TRITC (both from Pierce
Chemical Co.) was carried out essentially according to Adams et al.
(1991). The buffers of the protein solution (
 
z
 
0.5 mg/ml) were substituted
by 25 mM bicine, 0.1 mM EDTA, pH 8.0, using centrifuge concentrators
(Centricon; Amicon). The catalytic subunits were labeled with 0.3 mM
FITC or 0.5 mM TRITC in the presence of 8 mM MgC1
 
2
 
 and 5 mM ATP
to prevent inactivation of kinase activity. Labeling was allowed to proceed
for 30 min at room temperature, and then quenched by addition of 5 mM
glycine for 15 min. Excess dye was removed by passing each protein solu-
tion through a PD 10 column (Pharmacia) equilibrated with 25 mM potas-
sium phosphate buffer, pH 6.8, 0.5 mM EDTA, l mM DTT, 10% glycerol.
The labeled C-subunits were eluted with 3.5 ml of the above buffer and
adjusted to 1 mg/ml protein using Centricon and Minicon microconcentra-
tors for microinjection. The dye to protein stoichiometry was determined
by measuring absorbance at 495 nm for protein-bound fluorescein (assum-
ing an extinction coefficient of 65 
 
3 
 
10
 
3 
 
M
 
2
 
1
 
cm
 
2
 
1
 
), at 552 nm for protein-
bound rhodamine (assuming an extinction coefficient of 72 
 
3 
 
10
 
3
 
M
 
2
 
1
 
cm
 
2
 
1
 
), and measuring the protein concentration according to Brad- 
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ford (1976). FITC/protein ratios for fraction A and B were 
 
$
 
 0.9 mol
FITC per mole of C-subunit as indicated in Results. The TRITC/protein
ratio was 
 
$
 
 0.4 mol TRITC per mole of C-subunit. Dye conjugation had
no significant effect on the specific enzyme activity. The activity of labeled
enzymes could be inhibited by protein kinase inhibitor and by regulatory
subunit.
 
Expression and Purification of Recombinant myr-rC
 
a
 
 
and Mutants
 
Recombinant bovine catalytic C
 
a
 
 (Wiemann et al., 1992) was expressed
using vector pT7-7 in the 
 
Escherichia coli
 
 strain BL21(DE3) and purified
by affinity chromatography and FPLC separation on a Mono S column as
described (Girod et al., 1996), except that the vector pBB131 for the ex-
pression of yeast NMT was coexpressed together with C
 
a
 
 (Duronio et al.,
1990, Jedrzejewski et al., 1998), leading to virtually complete myristoyla-
tion of the catalytic subunit. The specific enzyme activity equaled that of
native enzyme obtained from heart muscle. Site-directed mutagenesis was
performed according to Kunkel (1985); the fragment was characterized by
sequencing and cloned into the expression vector pT7-7, coexpressed with
yeast NMT and purified as above.
 
Antibodies
 
Polyclonal antibodies against the C-subunit were raised in rabbits by two
intramuscular injections (3- wk interval) of 0.4–0.5 mg C-subunit (isolated
from bovine heart coupled to the same amount of hemocyanin by the use
of glutaraldehyde 0.5%, 15 min at room temperature) and incomplete
Freund adjuvants (1:1). After 
 
z
 
2 mo, the serum reacted with C-subunit at
a 4 
 
3 
 
10
 
4 
 
dilution in an ELISA. C-subunits from bovine and porcine ori-
gins were equally recognized by the antiserum. This was expected on the
basis of the high degree of sequence homology (Buechler et al., 1989;
Jedrzejewski et al., 1998). For some experiments, antibodies were purified
by affinity chromatography using immobilized bovine C-subunit (3 mg
coupled to 2 ml CNBr Sepharose; Pharmacia). Polyclonal rabbit antibod-
ies against CREB and CREB-(p)Ser133 were a gift of Dr. W. Schmid
(Division of Molecular Biology of the Cell I, German Cancer Center,
Heidelberg, Germany). Recombinant CREB protein for in vitro phos-
phorylation was a gift from D. Gau (Division of Molecular Biology of the
Cell I, German Cancer Center, Heidelberg, Germany).
 
Electrophoresis
 
Electrophoresis of fraction A and B in the presence of SDS was done in
11% polyacrylamide gels. The proteins were subsequently blotted to an
Immobilon-P membrane. For immunostaining of proteins after Western
blotting, the membrane was first soaked in TBS with 0.05% Tween 20 for
2 h, followed by incubation for at least 2 h with antibodies in TBS/0.05%
Tween 20 (TBS/T). The blot was washed three times in TBS/T and incu-
bated with peroxidase-coupled secondary antibody for 2 h. After another
wash, the blot was finally stained according to Kobayashi and Tashima
(1989).
 
Isoelectric Focusing of the C Subunit
 
Isoelectric focusing of the C-subunit was done in 1-mm ampholine gels,
pH 3.5–9.5 (Pharmacia), prefocused at 8 W until 500 V was reached. 1–2 
 
m
 
g
of the different C-subunits (labeled or unlabeled) diluted to 10 
 
m
 
l by water
was spotted 
 
z
 
3 cm away from the anode on the gel. The gel was run for 2 h
at 1,500V, 8W, and stained by Coomassie blue. 2 
 
m
 
g myoglobin of horse
and whale were used as pH markers.
 
Cell Culture and Microinjection
 
Mouse NIH 3T3 and HeLa cells were cultured as previously described
(Kinzel et al., 1988; Pepperkok et al., 1988, 1993a,b). For microinjection
experiments, cells were plated onto glass coverslips (10 
 
3 
 
10 mm) or in
glass bottom Microwell petri dishes (Mattek) and grown for 2 d (70% con-
fluency). For microinjection, cells were transferred into carbonate-free
culture medium containing 5% FCS and 20 mM Hepes. Microinjection
was performed at room temperature using a Zeiss automated injection
system (AIS; Ansorge and Pepperkok, 1988). About 0.1 pl of sample was
introduced into the cytoplasm of the cells representing 5–10% of the cell
volume. The C-subunit samples to be microinjected were adjusted to iden-
tical concentration for fraction A and B in individual experiments as given
in Results. Subsequently, microinjected cells were transferred into pre-
warmed carbonate-buffered culture medium and further incubated at
37
 
8
 
C and 5% CO
 
2
 
 for various periods as indicated.
 
Immunofluorescence and Fluorescence Microscopy
 
Cells microinjected with fluorescently labeled C-subunits were fixed with
3.5% paraformaldehyde for 20 min on ice, washed with PBS/BSA, and
mounted onto glass slides using 6 
 
m
 
l of Mowiol. In some experiments, in-
jected cells plated on glass bottom microwells were directly transferred to
the microscope for quantification of C-subunit fluorescence in living cells.
Cells injected with unlabeled C-subunit were fixed with ice-cold 100%
methanol for 4 min on ice. After fixation, they were washed extensively
with PBS containing 0.1% BSA (PBS/BSA), incubated with polyclonal
rabbit anti–PKA-AB (dilution 1:500) for 30 min at room temperature,
subsequently washed with PBS/BSA, and incubated for another 30 min
with rhodamine-conjugated goat anti–rabbit antibodies (Sigma Chemical
Co.; dilution 1:100). Coverslips were finally washed in PBS/BSA and
mounted onto glass coverslips as described above.
For immunostaining of CREB or phospho-CREB, injected cells were
fixed with 3.5% paraformaldehyde as described above, permeabilized
with 0.1% Triton X-100 in PBS for 4 min, and subsequently stained with
anti–CREB or anti–phospho-CREB antibodies for 20 min, followed by in-
cubation with ALEXA488-conjugated anti–rabbit antibodies (Molecular
Probes). Coinjected mouse IgGs were stained with Alexa568-conjugated
anti–mouse antibodies (Molecular Probes).
Images of stained cells were recorded either on a Zeiss inverted fluo-
rescence microscope (model 135TV; Axiovert) equipped with a cooled
slow scan CCD camera (model CH250; 1,317 
 
3 
 
l,035 pixels; Photometrics)
controlled by a Macintosh Quadra 900, or on a similar microimaging sys-
tem recently described (Pepperkok et al., 1993a,b). Images were further
processed and figures were arranged with the software package IPLab
spectrum V3.1 (Signal Analytics Corp.) and Adobe Photoshop 3.0.
Quantification of compartment-specific cellular fluorescence was per-
formed as described (Lorenz et al., 1993; Pepperkok et al., 1993a,b). Nu-
clear and cytoplasmic fluorescence intensities were determined separately
in single cells and from these values was subtracted the local background
intensity measured in neighboring uninjected cells by a background stain-
ing correction method described in Pepperkok et al. (1993a). The ratio of
the corrected nuclear and cytoplasmic fluorescence intensities (N/C) was
determined individually for each cell measured. In all experiments, C-sub-
unit fractions, A and B, from the same preparation were compared di-
rectly.
 
Results
 
Porcine PKA C-subunit Fraction A and B
 
To obtain the major fractions A and B of the C-subunit,
porcine catalytic subunit from the heart (Fig. 1, inset, lane
2) was chromatographed as described in Materials and
Methods and shown in Fig. 1. The fractions were charac-
terized by mass spectrometry as reported in detail else-
where (Jedrzejewski et al., 1998). The A/B ratio was 
 
z
 
1:2,
and the measured masses did not differ significantly:
40835.5 
 
6
 
 1.6 D for fraction A; and 40833.5 
 
6
 
 1.6 D for
fraction B. The molar phosphate content was 1.91 
 
6
 
 0.17
in fraction A and 1.98 
 
6
 
 0.14 in fraction B, indicating two
phosphorylation sites. For further characterization of both
fractions, tryptic digests were analyzed for the myristoy-
lated NH
 
2
 
-terminal peptides by 
 
m
 
LC-ESI-MS and by se-
quence analysis through tandem mass spectroscopy (sum-
marized in Table I). Fraction B contains the isozymes C
 
a
 
and C
 
b
 
 (
 
z
 
2.5:1) in the encoded form with Asn2; fraction
A contains the isozymes exclusively in the Asp2 form with
traces of isomers, which is indicative of a deamidation re-
action by the 
 
b
 
-aspartyl shift mechanism (for review see
Wright, 1991). Superimposable data were obtained in the
same study with C-subunit fractions A and B from bovine
heart (Jedrzejewski et al., 1998). Physical separation of C
 
a 
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and C
 
b
 
 is presently not possible. The data in Table I indi-
cate that C
 
a
 
 and C
 
b
 
 were deamidated to a comparable ex-
tent. No further differences between fractions A and B
were detectable. Therefore, it is reasonable to assume that
it is the Asn2 to Asp2 conversion that causes the 0.4-pH
unit difference in their isoelectric values and, thus, their
separation on cation exchange resins.
 
Microinjection of Dye-conjugated C-subunit Fractions
 
For microinjection in the first set of experiments, porcine
fractions A and B were labeled with fluorescein (FITC)
according to Adams et al. (1991), after which the enzymes
retained 
 
.
 
97% of their specific activity as measured by
phosphorylation of histone. The labeled enzymes were mi-
croinjected at room temperature into the cytoplasm of
subconfluent NIH 3T3 fibroblasts that were fixed either
immediately (1-min values) with paraformaldehyde or af-
ter incubation at 37
 
8
 
C for the indicated intervals. The in-
jection volume (
 
z
 
0.1 pl) was in the order of one tenth of
the cell volume. Thus, the amount of enzyme injected (1
mg/ml in the injection needle equivalent to 
 
z
 
25 
 
m
 
M) ex-
ceeded the cellular concentration (estimated in the range
of 0.2–0.8 
 
m
 
M in organ tissues; Hofmann et al., 1977; Loh-
mann and Walter, 1984).
Microinjected cells first emitted a strong fluorescence in
the cytoplasm, followed by a subsequent increase in the
nucleus. Cells fixed within 10 min after injection of the en-
zyme exhibited no morphological changes. However, be-
yond 10 min, injected cells started to develop morphologi-
cal characteristics (see below) as if they had been treated
with permeating cAMP derivatives or with agents causing
an increase of cellular cAMP, thus, indicating a functional
enzyme. No morphological changes were observed when
cells were injected with purified mouse or rabbit IgGs in
the injection buffer (data not shown).
For quantification of the cellular distribution of frac-
tions A and B after microinjections, the cells were further
incubated in the presence of 8-bromo-cAMP (1 mM; Byus
and Fletcher, 1982) to prevent reassociation with R-sub-
units. Quantification was obtained from images digitized with
a slow scan cooled CCD camera at 12-bit resolution as de-
scribed in Materials and Methods. At least 50 cells per group
and time point were analyzed and the ratio of nuclear/cyto-
plasmic fluorescence (N/C) was determined. The results,
given in Fig. 2, show that between 5 and 10 min after injec-
tion, the N/C ratios for A and B diverged and reached
 
z
 
2.8 and 4.8, respectively; i.e., the N/C ratio obtained with
fraction B exceeded that of fraction A 
 
z
 
1.7-fold. After 10
min, the curves seem to reach a plateau lasting for another
50 min at least, ruling out the possibility that the differ-
ences observed here for N/C ratios simply reflect different
cytoplasmic to nuclear transport kinetics for fractions A
and B. The data in Fig. 2 show that microinjected fraction
B reaches a significantly higher nuclear concentration than
microinjected fraction A. Moreover, the stability and du-
ration of the plateau phase obtained with both enzyme
fractions argues against a measurable interconversion of
fraction B into fraction A, i.e., against a significant deami-
dation during the experiment.
To see if the intracellular distribution of the FITC-con-
jugated fraction A and B was restricted to NIH 3T3 fibro-
blasts or represented a more general phenomenon, the flu-
orescent enzyme fractions were also injected into the
cytoplasm of HeLa cells held subsequently in the presence
Figure 1. Separation of electrophoreti-
cally homogenous PKA C-subunit (por-
cine heart) on cation exchange resin into
fractions A and B. (inset) Enzyme in SDS
gel stained with Coomassie blue: (lane 2)
molecular mass standard proteins ovalbu-
min 43 kD, and carboanhydrase 30 kD
(lane 1).
 
Table I. Isoenzyme Composition of Porcine Heart PKA
C-subunit Fraction A and B Indicated by the NH
 
2
 
-terminal 
Tryptic Fragments*
 
Fraction
NH
 
2
 
-terminal
tryptic fragments
 
‡
 
Isoenzyme Approximate percent
 
myr-
 
G
 
D
 
AAAAK
 
C
 
a
 
(Asp2) 66
A myr-G
 
iso
 
D
 
AAAAK
 
C
 
a
 
(
 
iso
 
Asp2) 8
myr-
 
G
 
D
 
AATAK
 
C
 
b
 
(Asp2) 23
myr-G
 
iso
 
D
 
AATAK
 
C
 
b
 
(
 
iso
 
Asp2) 3
B myr-
 
G
 
N
 
AAAAK
 
C
 
a
 
70
myr-
 
G
 
N
 
AATAK Cb 30
*Comparable data have been obtained with enzyme from bovine heart (for details see
Jedrzejewski et al., 1998).
‡Single letter code.
Figure 2. Cellular distribution of microinjected PKA C-subunit
fractions A and B labeled with fluorescein. NIH 3T3 cells were
microinjected at room temperature with fluorescein-conjugated
C-subunit fraction A or B, both at 1 mg/ml. Immediately after in-
jection, cells were transferred to prewarmed medium containing
1 mM 8-bromo-cAMP and incubated for the time indicated at
378C. Thereafter, cells were fixed with paraformaldehyde, and
the ratio of nuclear/cytoplasmic fluorescence was determined as
described in Materials and Methods. The averages and SDs of at
least two experiments with .50 cells quantified per time point
each are shown.Pepperkok et al. Subcellular PKA Distribution Altered by Deamidation 719
of 8-bromo-cAMP. Again, the N/C ratios of fraction A
and B reflected those obtained with mouse cells (data not
shown), indicating that the observed phenomenon was not
restricted to the particular cell system used.
If the minor molecular differences between fraction A
and B are responsible for a differential intracellular distri-
bution, the type of dye conjugated might influence the dis-
tribution as well. Therefore, fraction A and B were con-
jugated with a different dye, rhodamine (TRITC), and
microinjected into the cytoplasm of NIH 3T3 cells held
subsequently in the presence of 8-bromo-cAMP. The
N/C ratios obtained with the TRITC-conjugated fraction
A and B 10 min after injection in comparison with the
data obtained with FITC-conjugated enzyme fractions are
shown in Fig. 3. TRITC-conjugated fraction B reaches an
N/C ratio 2.3 times larger than TRITC-conjugated fraction
A. The comparable relationships of the N/C ratios indicate
that the enzyme distribution approached a similar balance
independent of the type of dye conjugated.
The possibility that the charge differences between both
enzyme fractions could contribute to the differential trans-
location behavior led to a control of the isoelectric val-
ues of conjugated enzymes. Labeling with rhodamine as
well as fluorescein lowered the isoelectric point of the re-
spective enzymes by .0.4 pH units. The data obtained
with FITC-conjugated C-isozymes are illustrated in Fig. 4
(lanes 4 and 5). Lane 1 shows the unlabeled electrophoret-
ically homogenous C-subunit preparation composed of the
two charge variants. Isolated native fraction A (lane 2)
and fraction B (lane 3) focus at about pH 7.1 and 7.5, re-
spectively. (The isoelectric values of Ca and Cb isozymes
were indistinguishable.) Occasionally, fraction B may con-
tain traces of the more acidic A fraction because of some
spillover on the column. Upon FITC conjugation of frac-
tion A (lane 4) and fraction B (lane 5) (labeling ratio 0.9,
respectively, 1.3 mol FITC/mol C-subunit), the major
amount of protein is shifted in both cases towards a more
acidic value. In the case of fraction B (lane 5), it should be
noted that the major portion of the labeled enzyme is
more acidic than the unlabeled fraction A, and that a fur-
ther protein band appears at an even lower pH, possibly
representing enzyme with 2 mol FITC bound per mole.
Microinjection of Native C-subunit Fractions
To evaluate further to what extent the dye modification
might contribute to the observed subcellular distribution,
native catalytic subunit fractions A and B were used for
microinjection. Detection was carried out using antibodies
after the enzymes had equilibrated intracellularly. Anti-
bodies distinguishing specifically between fraction A and
B are not available. Therefore, the rationale behind the fol-
lowing experiments was that upon microinjection, the cel-
lular concentration of the particular fraction injected
would be high enough to be dominantly detected above
the endogenous cellular level. The antiserum reacted with
C-subunit at a 4 3 104 dilution. The reactivity of the anti-
serum against separated fractions A and B (tested in
ELISA assays) was equal. In Western blots of SDS gels,
small amounts of enzyme in fractions A and B were simi-
larly well detectable by the antiserum. Together, these
data indicated that fractions A and B had a comparable af-
finity to the antibodies.
Purified fractions A or B (both at 4 mg/ml) were micro-
injected into the cytoplasm of NIH 3T3 fibroblasts. They
were incubated for 30 min at 378C, fixed with methanol,
incubated with affinity-purified antibodies, and stained
with the fluorescent secondary antibody. As shown in Fig.
5, for the antibody dilutions used, the microinjected cells
showed a strong fluorescent signal. In contrast, little fluo-
rescence (,25% of the signal of injected cells) was ob-
tained in noninjected cells (marked by stars in Fig. 5). Dis-
crimination between injected and noninjected cells was
facilitated by the increased appearance of growth cones
(Fig. 5, A and B, arrows) in cells injected with either frac-
tion A or B. At time points longer than 30 min after micro-
injection, rounding up of the cells was observed (not
shown). Similar morphological changes upon microinjec-
tion of the C-subunit into living cells have been reported
by others (e.g., see Lamb et al., 1988, 1989). They seem to
indicate that the injected enzyme is functional. In all in-
jected cells, a significant fluorescence signal was obtained
Figure 3. Comparison of the cellular distribution of microin-
jected PKA C-subunit fractions A and B conjugated with
rhodamine or fluorescein. NIH 3T3 cells were microinjected at
room temperature with labeled C-subunit fractions adjusted to 1
mg/ml. After a 10-min postinjection incubation at 378C in the
presence of 1 mM 8-bromo-cAMP, cells were fixed and the nu-
clear to cytoplasmic fluorescence was determined as described in
Materials and Methods. The averages and SDs of two experi-
ments with at least 60 cells quantified per group are shown.
Figure 4. Isoelectric focusing results obtained with native por-
cine PKA C-subunit, before (lane 1) and after separation in frac-
tion A (lane 2) and fraction B (lane 3). Fluorescein-labeled frac-
tions A and B are shown in lane 4 and 5 respectively. Arrows
indicate the native and the predominantly labeled fraction A (c)
and B (x).The Journal of Cell Biology, Volume 148, 2000 720
in the cytoplasm and the nucleus. For both microinjected
fraction A and B, an increased nuclear fluorescence was
observed (Fig. 5).
After injection of native fraction A and B (4 mg/ml
each), the nuclear and cytoplasmic fluorescence in injected
cells was quantified as before. To prevent association with
cellular R-subunits, 5 mM cAMP (in the pipette) was coin-
jected. The N/C ratios of the experiments are shown in
Fig. 6. The 5-min values are almost identical. However, be-
tween 5 and 10 min, a pronounced increase of the N/C ra-
tio was seen with fraction B surpassing that obtained with
fraction A by z1.5-fold. 30 min after injection, the N/C
value for fraction B was 1.6-fold larger than that with frac-
tion A. The time course and the relative distribution of
fractions A and B mirror the results obtained with fluores-
cent probes (Figs. 2 and 3). Taken together, the data with
native fractions A and B from porcine origin suggest that
deamidation of Asn2 is sufficient to attenuate the nuclear
concentration of the C-subunit. Moreover, the results indi-
cate that dye conjugation as such did not profoundly alter
the intracellular behavior of C-subunit isozymes.
The experiments described so far were done with the
porcine enzyme. To see how an enzyme from a different
species behaves, native fractions A and B from the bovine
heart were prepared (the mass of fraction A was 40,858.4 6
1.6 D; that of fraction B 40,855.7 6 1.6 D) and injected
(4 mg/ml) into NIH 3T3 cells (together with 5 mM cAMP
in the pipette). After a 10-min resp., 30 min incubation at
378C cells were fixed, incubated with the affinity-purified
antibodies, and stained with the secondary antibody as
above. The N/C ratios obtained (Table II) reproduce those
obtained with porcine enzymes; the N/C ratio for fraction
B exceeded that of fraction A at 10 and 30 min by z1.8-
fold. Comparison of the 10- and 30-min values shows again
that the equilibrium was nearly complete after z10 min.
That the data with the bovine enzyme is so similar to that
obtained with porcine enzyme implies that this phenome-
non is independent of the origin of the enzyme.
A survey of the experiments carried out during this
study, including all the repeats, showed that the N/C ratios
(including 10- and 30-min values) obtained with FITC-
and TRITC-labeled as well as unlabeled enzyme ranged
for fraction A from 1.9 to 2.9; and for fraction B from 3.7
to 6.8. The variation appeared to be independent of the
detection method (even though the unlabeled enzyme was
injected at a four times larger concentration than the la-
beled enzymes). It should be noted that the two enzyme
fractions from the same preparation were always com-
pared within the same experiment, and that the individual
results reached a comparable level within the particular
Figure 5. Localization of microinjected PKA
C-subunit fraction A and B by immunofluores-
cence. Purified porcine C-subunit fractions A
and B (4 mg/ml each) were injected with 5 mM
cAMP (in the pipette) into the cytoplasm of NIH
3T3 cells. After injection, cells were incubated at
378C for different periods (30 min shown here)
before they were fixed and stained for C-subunit
using a polyclonal rabbit antibody and corre-
sponding rhodamine-conjugated secondary anti-
bodies (see Materials and Methods). The anti-
PKA antibody was diluted sufficiently that only
microinjected cells showed a significant fluores-
cent staining specific for microinjected C-sub-
unit. Asterisks indicate the nucleus of neighboring noninjected cells. The image contrast was adjusted to better visualize growth cones in
injected cells (marked by arrows). Therefore, the nucleus in the cell injected with fraction B appears to be saturated. As in the other ex-
periments, for the quantification of N/C values, the original images were used where the gray values in all the images were always below
the saturation level. The mean N/C ratio 6 SD determined in this experiment from .100 cells was 1.9 6 0.2 for fraction A and 3.3 6 0.5
for fraction B at 30 min. Bar, 20 mm.
Figure 6. Cellular distribution of PKA C-subunit fractions A and
B detected by immunofluorescence. Cells were treated and in-
jected as described in the legend of Fig. 5. The ratio of nuclear to
cytoplasmic fluorescence was determined as described in Materi-
als and Methods. The averages and SDs of six different experi-
ments with at least 40 cells quantified for each value are shown.
Table II. Bovine Heart PKA C-subunit: Nuclear/cytoplasmic 
Distribution of Microinjected Native Enzyme Fractions A and 
B in NIH 3T3 Cells Analyzed by Immunofluorescence
Time Nuclear/cytoplasmic fluorescence
min
Fraction A Fraction B
10 2.1 6 0.2 (114)* 3.7 6 0.6 (128)
30 2.3 6 0.4 (154) 4.2 6 0.3 (153)
*Number of cells analyzed.Pepperkok et al. Subcellular PKA Distribution Altered by Deamidation 721
range of a group. Accordingly, the apparent nuclear fluo-
rescence level of fraction B surpassed that of fraction A
1.5–2.3 times, i.e., the B/A ratio of the N/C values varied
comparably little, between 1.5 and 2.3.
To evaluate the possibility that the apparent differences
of the N/C ratios obtained with the fractions A and B were
caused by a preferential degradation of one of the frac-
tions within a particular subcellular compartment, the to-
tal cellular amount of enzyme detectable by immunofluo-
rescence was determined, and the results obtained for A
and B were compared with each other. The data (Fig. 7)
indicate that fractions A and B do not decay to a different
extent. Injected dye-conjugated C-subunit fractions A and
B decayed at a similar rate (not shown). Therefore, the
N/C ratios indeed seem to reflect a different intracellular
distribution.
Microinjection of Recombinant C-subunit
Since the enzyme isolated from porcine as well as bovine
heart in fraction B is composed of z70% Ca and 30% Cb
isozymes as indicated in Table I, a control experiment with
recombinant Ca was carried out. For this purpose, the bo-
vine Ca sequence (Wiemann et al., 1992) was coexpressed
in E. coli together with NMT to obtain myristoylated re-
combinant bovine Ca (Duronio et al., 1990; Jedrzejewski
et al., 1998). The enzyme was purified by affinity chroma-
tography followed by FPLC chromatography on a Mono S
column. The doubly phosphorylated form was injected (4
mg/ml together with cAMP) into the cytoplasm of NIH
3T3 cells and allowed to equilibrate at 378C for 10 min.
The N/C ratio detected by indirect immunofluorescence
was 4.8 6 0.7; i.e., well within the range of values obtained
with fraction B in native and dye-conjugated forms.
A control with a recombinant enzyme mimicking the
Asp2 consensus form in fraction A was not possible since
the NH2-terminal sequence Gly-Asp-X unlike Gly-Asn-X
is not a substrate of NMT (Towler et al., 1988). Coexpres-
sion of the rCaAsn2Asp mutant with NMT in E. coli did
not yield myristoylated enzyme (Jedrzejewski et al., 1998).
Moreover, a procedure for specifically deamidating Asn2
of Ca in vitro is not available yet. Therefore, one is limited
in this respect to the fraction A isolated from tissue. To
evaluate a potential role of Asn2 for the intracellular dis-
tribution of the enzyme, Asn2 was deleted from bovine
Ca, and the enzyme was coexpressed with NMT in E. coli.
The resulting protein was myristoylated; the doubly phos-
phorylated form was isolated, concentrated, and injected
into the cytoplasm of NIH 3T3 cells in the presence of
cAMP. After a 10-min incubation at 378C, the cells were
fixed and the N/C ratio was analyzed by the use of anti-
bodies. This deletion mutant reached 5.5 6 0.5, a value
well within the range of data obtained with fraction B, in-
dicating that Asn2 per se is not a determinant for the nu-
clear/cytoplasmic distribution of the enzyme.
Functional Significance of C-subunit Deamidation
The cyclic AMP–responsive transcription factor CREB
and related transcription factors (for simplicity subse-
quently referred to as CREB) can be regulated by phos-
phorylation of a key serine (Ser133 in CREB) within a
conserved subdomain by a number of protein kinases in-
cluding PKA (for reviews see De Cesare et al. 1999; Shay-
witz and Greenberg, 1999). To test if the microinjected en-
zyme fractions exhibit catalytic activity in vivo according
to their differential intracellular distribution, the phosphor-
ylation of the key serine residue was analyzed by the use
of antibodies that specifically recognize the phospho form
of this epitope, i.e., CREB-(p)Ser133. For comparison, in
vitro studies with recombinant CREB were carried out. In
the test tube, the phosphorylation of recombinant CREB
by both fractions did not differ as the Western blot analy-
sis of electrophoresed samples revealed (data not shown),
thus, supporting earlier observations that different PKA
substrates were phosphorylated in vitro by both enzyme
fractions to the same extent (Kinzel et al., 1987). For the in
vivo phosphorylation of the CREB enzyme, fractions A
and B (1 mg/ml) were microinjected in the cytoplasm of
NIH 3T3 cells; after a 25-min incubation at 378C, the cells
were fixed. Microinjected cells were identified by the
detection of coinjected IgGs (Fig. 8, B and D) and simul-
taneously stained with primary anti–CREB and anti–
CREB-(p)Ser133 antibodies (Fig. 8, A and C). The CREB
signal as such was not altered by the microinjection of
both enzyme fractions (data not shown). The phospho-
CREB signal in cells injected with fraction B was stronger
than in cells injected with the enzyme fraction A (Fig. 8, A
versus C). The quantified phospho-CREB–specific signals
in the nuclei of cells injected with different amounts of the
enzyme fractions are plotted as a percentage of the maxi-
mal response seen (Fig. 8 E). The data demonstrate that
up to an enzyme concentration of 2 mg/ml (in the microin-
jection pipette) CREB phosphorylation by fraction B ap-
Figure 7. Decay of microinjected PKA C-subunit fraction A and
B. NIH 3T3 cells were microinjected with purified PKA C-sub-
unit fraction A or B at 4 mg/ml. At different time points after in-
jection, cells were fixed and stained by immunofluorescence for
injected PKA and subsequently mounted on glass slides. Images
of injected cells were acquired as described in Materials and
Methods. The average PKA-specific fluorescence intensity (in-
cluding the nucleus and cytoplasm) in injected cells was deter-
mined, and the value obtained for cells fixed immediately after
injection (t 5 0) was set at 100%. The averages and SDs of two
independent experiments with at least 65 cells measured are
shown. Degradation of the injected PKA proteins appeared to be
similar for the fraction A and B.The Journal of Cell Biology, Volume 148, 2000 722
pears to be more efficient during 25 min than by fraction
A. At 3.5 mg/ml, the 25-min period is sufficient for fraction
A to phosphorylate CREB to the same extent as fraction B,
possibly indicating substrate limitation. In contrast to
the phosphorylation mediated by fraction B, that effected
by fraction A exhibits an almost linear concentration de-
pendence up to 1 mg/ml. In this range, the largest differ-
ences in the phosphorylation of CREB by fraction A and
B were observed. It should be noted that the two smallest
concentrations injected (0.25 and 0.5 mg/ml) lead to and
represent enzyme levels that are within the physiological
range (Hofmann et al., 1977; Lohmann and Walter, 1984).
A small concentration was chosen to test the time course
of CREB phosphorylation by both enzyme fractions (Fig.
8 F). For this purpose, NIH 3T3 cells were microinjected
with 0.5 mg/ml of fraction A or B at time zero, and incu-
bated at 378C for various periods as indicated before they
were fixed and stained for phospho-CREB analysis. The
data show again that fraction B causes a more pronounced
phospho-CREB appearance than fraction A. The 25-min
values agree with those seen with the same concentration
in the previous analysis (Fig. 8 E). The onset of CREB
phosphorylation by enzyme fraction B appears to be faster
than that effected by fraction A. The intensity of CREB
phosphorylation peaks at z20–25 min after the injection
of both enzyme fractions with a subsequent takeover of
dephosphorylation. Taken together, the data on CREB
phosphorylation obtained with both enzyme fractions
mirror the differential intracellular distribution of the
encoded and the deamidated forms of the PKA catalytic
subunit, and illustrate at the same time functional conse-
quences of Asn2 deamidation.
Discussion
The biological significance of the NH2-terminal domain of
the PKA C-subunit, a segment comprising z40 residues
that precedes the catalytic domain, is unknown. In the
crystal structure, it forms an amphipathic a-helix (Veron
et al., 1993) and reaches from the large to the small lobe of
the enzyme opposite the catalytic cleft (Knighton et al.,
1991; Bossemeyer et al., 1993). The NH2 terminus myrGly-
Figure 8. CREB phosphorylation by microinjected PKA C-subunit fraction A
and B. (A–D) Purified PKA C-subunit fraction A (C and D) and B (A and B)
were microinjected into the cytoplasm of NIH 3T3 cells at room temperature at
a concentration of 1 mg/ml (for details see Fig. 5 legend). To identify injected
cells, purified mouse IgGs (1 mg/ml) were coinjected. At 25 min after injection
and incubation at 378C, cells were fixed and stained for injected mouse IgGs and
CREB-(p)Ser133 using primary anti–phospho-CREB antibodies. Arrows in A
and C indicate the position of injected cells. (E) Different concentrations of pu-
rified PKA C-subunit fraction A or B, as indicated, were microinjected into the
cytoplasm of NIH 3T3 cells together with purified mouse IgGs (1 mg/ml) to
identify injected cells. Cells were incubated and stained for IgGs and CREB-
(p)Ser133 as described in A–D. The phospho-CREB–specific signal in the nu-
cleus of injected cells was quantified as described in Materials and Methods. (F)
Purified PKA C-subunit fractions A or B (0.5 mg/ml) were microinjected at
room temperature and subsequently incubated at 378C for the periods indicated. The detection of microinjected cells, staining, and
quantification of CREB phosphorylation was as above. In E and F, the means 6 SDs of at least 60 cells are shown for each data point.
The values have been normalized to the maximum average nuclear intensity obtained for cells injected with enzyme fraction B (at a
concentration of 3.5 mg/ml; E, respectively incubated for 20 min; F). Bar, 20 mm.Pepperkok et al. Subcellular PKA Distribution Altered by Deamidation 723
Asn-Ala is conserved among the isozymes Ca, Cb, and Cg,
the latter being expressed in the testis (Beebe et al., 1990).
We have shown previously that Ca and Cb are prone to
deamidation at Asn2, since about one-third of the C-sub-
unit isolated from striated muscle of four different mam-
malian species (pig, cattle, rabbit, and rat) are in the myr-
Gly-Asp-Ala configuration, which is an NH2-terminal
sequence not so far present in protein data banks. There is
evidence that deamidation of the C-subunit occurs in vivo
(Jedrzejewski et al., 1998). The physiological significance
of the Asp2 form is certainly not limited to the fact that it
is more resistant towards a specific protease isolated from
kidney brush border membranes than the Asn2 form (Kin-
zel et al., 1987). The finding that after microinjection, the
Asn2 form reaches a significantly larger nuclear/cytoplas-
mic ratio than the Asp2 form constitutes evidence that the
NH2 terminus of the C-subunit is critical for the intracellu-
lar distribution of the enzyme. This difference between the
encoded and the deamidated form has been observed re-
gardless of whether the C-subunit was labeled with FITC,
TRITC, or was in unlabeled form. The N/C ratio in the
plateau phase with the Asn2 form was z1.5–2.3 times
greater than that observed with the Asp2 form. The differ-
ence in the intracellular distribution appears to be inde-
pendent of the mammalian species, as enzymes from two
different sources behave in the same manner, and the mo-
lecular parameters from two further mammalian species
reproduce those seen with the former (Jedrzejewski et al.,
1998). This apparent independence of the data from the
cell type used suggests a general mechanism designed to
discriminate between the two forms of the enzyme.
The relatively large amounts of microinjected C-subunit
fractions required to measure the intracellular distribution
may question the potential physiological significance of
the results. However, the significance is supported by data
on the site-specific phosphorylation of nuclear CREB, a
reaction known to activate the transcription factor, elicited
by the small enzyme amounts injected. The differential
phosphorylation by fraction A and B is particularly well
demonstrable at the small enzyme amounts, which yield
intracellular concentrations in the physiological range.
Under these conditions, nuclear substrate is probably not
a limiting factor. The encoded, Asn 2 form of the PKA
C-subunit is more efficient in that respect than the deami-
dated, Asp2 form. Since in vitro both enzyme fractions
were shown to phosphorylate PKA substrates (Kinzel et
al., 1987), including CREB equally effective, the data indi-
cate that the differences observed in vivo are based on the
uneven intracellular distribution; i.e., the larger nuclear
level of the encoded C-subunit. The distribution data and
the degree of protein phosphorylation in the nucleus cor-
relate. Therefore, the differential distribution of both en-
zyme fractions observed at high concentrations is unlikely
to be caused by this fact, but appears to reflect a physio-
logical relevance.
The difference in the N/C ratios observed for fraction A
and B might suggest in the first instance that it is the in-
crease in electronegativity that causes a decrease of the
nuclear enzyme level of fraction A. A simple charge differ-
ence as the driving force for the variant distribution of the
Asn2 and the Asp2 form is unlikely, however, because of
the fact that FITC labeling renders fraction B even more
acidic than the unlabeled fraction A (Fig. 4), yet it, never-
theless, reaches larger N/C values than the latter. There-
fore, it seems that a negative charge alone is not sufficient
to explain the decrease in the nuclear level of the enzyme,
but that it must probably be added at a specific site.
The Asn2 residue per se does not appear to constitute
a determinant for the intracellular enzyme distribution
as its deletion does not alter the N/C ratio of the deletion
mutant when compared with the wild-type enzyme. It ap-
pears that Asn2 plays a role as a deamidation site only,
conserved in Ca, Cb, and Cg and, thus, as a potential
source for increasing electronegativity at the NH2 termi-
nus, and perhaps with the further consequence of facilitat-
ing Ser10 autophosphorylation. Since a negatively charged
residue next to Gly1 inhibits N-myristoylation (Towler et
al., 1988), deamidation appears to be the only way to
achieve the specific sequence myrGly1-Asp2 observed in
fraction A.
The gain in electronegativity close to the NH2-terminal
myristoyl moiety in proteins is reminiscent of myristoyl-
electrostatic switch proteins (for review see, McLaughlin
and Aderem, 1995) in which electronegativity is achieved
through phosphorylation aimed at influencing the interac-
tion of these proteins with membranes. This is usually me-
diated by the myristoyl moiety partitioning into the lipid
bilayer with positively charged residues interacting with
acidic phospholipid head groups. Thus, it is possible that a
lipophilic entity of membranous or proteinaceous nature
may participate in the recognition and in the determina-
tion of the intracellular distribution of the C-subunit. It
has been shown that the NH2 terminus of the PKA C-sub-
unit in chimeric pp60v-src can partially substitute for the
wild-type NH2 terminus in conferring membrane binding
in vivo (Silverman and Resh, 1992). However, this obser-
vation with the myristoylated NH2 terminus of the C-sub-
unit within the foreign structural context of another pro-
tein may not necessarily reflect its natural role in PKA. A
PKA-specific significance of its myristoylated NH2 termi-
nus may be indicated by the finding that the rate of C-sub-
unit binding to liposomes in vitro is dramatically increased
on interaction with the regulatory subunit type II (RII)
but not with type I (Gangal et al. 1999). Even these PKA-
specific observations, however, are unlikely to play a role
since the experiments in our study were carried out under
saturating amounts of cAMP and with excess of free
C-subunit sufficient to guarantee subunit dissociation and
to exclude a role of R-subunit isoforms.
Results published so far on the cytoplasmic to nuclear
translocation of the free C-subunit are compatible with a
model in which the enzyme can traverse nuclear pores in
either direction by diffusion (Harootunian et al., 1993). A
functional nuclear localization signal has not been identi-
fied yet in C-subunits. In agreement with a diffusion
model, the distribution is not particularly influenced by
the concentration of the C-subunit. In our study, the unla-
beled enzymes were injected at a four times larger concen-
tration than the labeled enzymes. The N/C ratios of the
plateau, however, reach comparable values characteristic
for a specific isoform, indicating that it is not saturable, at
least not within this range. However, the observation that
both forms of the enzyme after z10 min reach an equilib-
rium which is different for the deamidated and the non-The Journal of Cell Biology, Volume 148, 2000 724
deamidated forms, seems to require supplementary as-
sumptions for explanation.
Deamidation of Asn2 might, of course, result in changes
of the higher ordered structure of the NH2 terminus. No
noticeable structural differences are apparent between the
high resolution structure of the fraction A enzyme (Bosse-
meyer et al., 1993) and the recombinant bovine (Engh et al.,
1996) or mouse (Knighton et al., 1991) enzyme; however,
the immediate area around Asn2 is not well resolved in the
ternary structure (Bossemeyer et al., 1993; Zheng et al.,
1993). Comparative secondary structure studies of syn-
thetic myristoylated hexadecapeptides representing the
bovine Ca NH2 terminus either in the Asn2 and the Asp2
form provided no evidence for significant structural differ-
ences at this level (Tholey, A., D. Bossemeyer, V. Kinzel,
and J. Reed, unpublished data). This still does not mean
that a different structure or flexibility might not occur. It
could be induced by interaction with cellular target(s), a
possibility indicated indirectly by RII-induced binding of
C-subunits to liposomes in vitro, which was not seen with
RI (Gangal et al. 1999). The charge shift to a more acidic
character of the NH2 terminus could be sufficient to result
in a preference for cytoplasmic structures that would re-
tain fraction A to a certain extent in the cytoplasm, or a
more favorable environment for the less acidic fraction B
in the nucleus. The described differences in the sensitivity
of fraction A and B to a specific protease in vitro (Kinzel
et al., 1987) suggests that such differences are in principle
recognizable at the molecular level. A differential export
from the nucleus (Schmidt-Zachmann et al., 1993), medi-
ated in the case of the C-subunit by protein kinase inhibi-
tor protein (PKI) (Fantozzi et al., 1994), represents an-
other possibility that requires further attention.
The fact that the different N/C ratios for fraction A and
B are seen in the presence of saturating amounts of cAMP
seems to argue against R-subunits as a retaining principle.
The interaction of enzyme fractions A and B with RI or
RII appeared to be indistinguishable in vitro (Kinzel et al.,
1987). However, it is not excluded that the affinity of type
II R-subunits for C-subunits in situ may be modulated by
association with anchor proteins (Scott, 1991; Hubbard
and Cohen, 1993) in such a way that the isozymes are
bound to a different extent. A preferential binding of cell-
endogenous PKI to the Asp2 form of the enzyme seems
unlikely, however, as the cause for differential nuclear up-
take since both enzyme fractions appeared to interact
equally well with PKI, at least in vitro (Kinzel et al., 1987;
Van Patten et al., 1988). Again, the isozymes might bind to
cytoplasmic substrates to a different extent. The finding
that the phosphorylation by fraction A and B of standard
substrates including CREB in vitro was identical does not
reflect the situation in the living cell (Lamb et al., 1988,
1989; this study).
The example of the C-subunit may be typical of cases
where proteins fulfill nuclear as well as cytoplasmic func-
tions. Such proteins may adapt intermediate states of in-
tracellular distribution by different mechanisms. One of
them seems to be site-specific deamidation, as shown in this
study. The circumstances in cells that control the partial
deamidation of certain proteins are unknown and may
even differ among candidate proteins; those for the C-sub-
unit are unknown as well. However, they may play an im-
portant role in those cells or tissues in which the C-subunit
is required to fulfill specific cytoplasmic functions. A pref-
erentially deamidated state of the C-subunit may explain
the lack of a significant redistribution of the enzyme to
the nucleus upon treatment of certain cells with 8-bromo-
cAMP (Murtaugh et al., 1982). The occurrence of compa-
rable fraction A/fraction B ratios in muscle tissues of
different mammalian species (Kinzel et al., 1987; Jedrze-
jewski et al., 1998) seems to point to a physiological sig-
nificance of this modification. An example of protein-
mediated deamidation of a cellular protein at a specific
glutamine residue caused by a bacterial toxin has been de-
scribed recently (Flatau et al., 1997; Schmidt et al., 1997).
Moreover, several myristoylated proteins involved in sig-
nal transduction share the NH2-terminal myr-Gly-Asn se-
quence and, thus, may be candidates for partial deamida-
tion (listed by Jedrzejewski et al., 1998).
Although the isoAsp2 form of the enzyme cannot be
evaluated separately, its presence in trace amounts in frac-
tion A is worth mentioning in the context of this study.
The occurrence of isoAsp2 in the C-subunit fraction A
points to a mechanism of deamidation through the so-
called b-aspartyl-shift mechanism (for review see Wright,
1991). It involves the formation of a cyclic succinimide in-
termediate that opens to yield preferentially the isoAsp
form (to a lesser extent the Asp form) (for reviews see
Bornstein and Balian, 1977; Aswad and Johnson, 1987;
Geiger and Clarke, 1987; Lura and Schirch, 1988; Artigues
et al., 1990), which carries the original Cb-methylene of
Asn2 now in the peptide backbone. The inverse ratio of
isoAsp/Asp in tissues, with a clear-cut surplus of the Asp
form, is probably due to the action of a ubiquitous repair
enzyme, protein carboxyl methyltransferase, which methy-
lates the atypical a-carboxyl group of L-isoAsp residues
(Aswad, 1984; Murray and Clarke, 1989) as a part of a
mechanism aimed at the reconstitution of the regular pep-
tide backbone. For a more detailed discussion of this rela-
tion with respect to the C-subunit see Jedrzejewski et al.
(1998). Cases of site-specific nonenzymatic deamidation of
proteins have been reported, which appear to be involved
in aging and subsequent degradation of proteins. How-
ever, in certain proteins, this type of modification appears
to be part of their physiological program (for review see
Wright, 1991). The conserved Asn2 deamidation of the
PKA C-subunit with signs of ample repair (to yield pre-
dominantly the Asp 2 form) may belong to the latter
group. This appears to be supported by the differential in
vivo phosphorylation of the CREB family transcription
factor(s) effected by the encoded and the deamidated
C-subunit.
In conclusion, this study with living cells allows for the
first time to consider different physiological functions of
the major C-subunit isozymes of PKA (generated by de-
amidation of Asn2) on the basis of their differential distri-
bution within cells, and points to a potential physiological
significance of the NH2-terminal domain of this enzyme,
and possibly of other proteins with a similar NH2 terminus
for which the C-subunit may represent a model system.
Further studies are aimed at the elucidation of the control
of deamidation and of the molecular mechanism responsi-
ble for the altered intracellular distribution of Asn2 deam-
idated catalytic subunit.Pepperkok et al. Subcellular PKA Distribution Altered by Deamidation 725
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